De forholdsregler, der træffes ved fremstilling af KIOVIG, betragtes som effektive for virus som human immunodeficiens- virus (HIV), hepatitis B- virus og hepatitis C- virus samt non- enveloped hepatitis A virus og parvovirus B19.
The measures taken for the manufacture of KIOVIG are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus, and for the non- enveloped hepatitis A virus and parvovirus B19.